Recanalization strategies in childhood stroke in Germany

Martin Olivieri1, Anna-Lisa Sorg2, Raphael Weinberger2

  • 1Pediatric Hemostasis and Thrombosis Unit, Department of Pediatrics, Dr Von Hauner Children's Hospital, University Hospital, LMU Munich, Lindwurmstr. 4, 80337, Munich, Germany. martin.olivieri@med.uni-muenchen.de.

Scientific Reports
|June 26, 2021
PubMed

Insights

Recanalization therapy is a feasible and increasingly used treatment for childhood arterial ischemic stroke (CAIS). Timely diagnosis and expert care can improve treatment times for pediatric stroke patients.

Area of Science:

  • Pediatric Neurology
  • Vascular Neurology
  • Rare Diseases

Background:

  • Childhood arterial ischemic stroke (CAIS) is rare, with varied causes and symptoms complicating diagnosis.
  • Delayed diagnosis hinders prompt recanalization strategies in pediatric stroke.

Purpose of the Study:

  • To analyze recanalization therapy outcomes in a subgroup of pediatric AIS patients.
  • To compare characteristics and treatment times between patients receiving recanalization therapy and the overall AIS cohort.

Main Methods:

  • Retrospective analysis of 164 pediatric first-time AIS cases (age >28 days to 18 years) from 2015-2017.
  • Subgroup analysis focused on 28 patients (17%) who received recanalization therapy.
  • Comparison of diagnostic and treatment times between the intervention and overall groups.

Main Results:

  • Patients receiving recanalization therapy had a significantly shorter time from symptom onset to diagnosis (4.1h vs. 20.4h).
  • Hemiparesis, facial weakness, and speech disturbance were common symptoms in the recanalization group.
  • Cardiac disease was a more frequent risk factor in the recanalization group; only one minor bleed occurred.

Conclusions:

  • Recanalization therapies are feasible and increasingly utilized in pediatric AIS.
  • High awareness, rapid diagnosis, and specialized expertise are crucial for improving hyperacute treatment in children.
  • Optimizing these factors can expand the availability of time-sensitive therapies for pediatric stroke.

Related Concept Videos